HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen P DiDonato Selected Research

Sufentanil (Sufenta)

2/2020Pooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain.
5/2019Pooled Phase III safety analysis of sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain.
10/2018An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain.
6/2018Sufentanil sublingual tablet 30mcg for moderate-to-severe acute pain in the ED.
1/2017Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo-Controlled, Phase-3 Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen P DiDonato Research Topics

Disease

3Acute Pain
02/2020 - 06/2018
2Postoperative Pain
10/2018 - 01/2017
2Pain (Aches)
06/2018 - 01/2017
1Weight Loss (Weight Reduction)
11/2012
1Obstructive Sleep Apnea
11/2012
1Apnea
11/2012

Drug/Important Bio-Agent (IBA)

5TabletsIBA
02/2020 - 01/2017
5Sufentanil (Sufenta)FDA LinkGeneric
02/2020 - 01/2017
2Opioid Analgesics (Opioids)IBA
06/2018 - 01/2017
1Analgesics (Analgesic Drugs)IBA
06/2018
1Phentermine (Adipex-P)FDA LinkGeneric
11/2012
1Topiramate (Topamax)FDA LinkGeneric
11/2012
1Delayed-Action PreparationsIBA
11/2012

Therapy/Procedure

1Ambulatory Care (Outpatient Care)
01/2017